SURGICAL REMOVAL AFTER IATROGENIC SUBRETINAL INJECTION OF AN INTRAVITREAL DEXAMETHASONE IMPLANT

Retin Cases Brief Rep. 2022 Nov 1;16(6):727-730. doi: 10.1097/ICB.0000000000001034.

Abstract

Purpose: To report a rare case of subretinal migration of an intravitreal dexamethasone implant to treat macular edema secondary to diabetic retinopathy in a vitrectomized eye and the surgical outcome.

Observations: A pars plana vitrectomy and a retinotomy were performed to remove the implant and restore vision.

Conclusion and importance: Subretinal dislodgement of intravitreal implants is a rare and preventable complication. In the current case, we speculated that this complication might have been related to the injection technique, a possible unrecognized retinal perforation before the injection of the implant, or delayed treatment with the implant. Because a retinal detachment and vitreoretinal proliferation were observed, surgical management was required. Increasing widespread application of any technology may lead to a more significant risk of complications, and ophthalmologists should be aware of this potential risk.

Publication types

  • Case Reports

MeSH terms

  • Dexamethasone* / adverse effects
  • Drug Implants / adverse effects
  • Glucocorticoids* / adverse effects
  • Humans
  • Iatrogenic Disease
  • Intravitreal Injections
  • Visual Acuity
  • Vitrectomy / adverse effects

Substances

  • Dexamethasone
  • Drug Implants
  • Glucocorticoids